LongView Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$318K Hold
471
– – 0.08% 175
2026
Q2
$236K Sell
471
-5
-1% -$2.4K 0.06% 212
2026
Q1
$251K Buy
476
+1
+0.2% +$543 0.06% 217
2025
Q4
$292K Sell
475
-2
-0.4% -$1.13K 0.07% 206
2025
Q3
$231K Buy
+477
New +$222K 0.06% 212
2025
Q2
– Sell
-476
Closed -$237K – 221
2025
Q1
$237K Sell
476
-29
-6% -$15.7K 0.07% 185
2024
Q4
$263K Sell
505
-7
-1% -$3.85K 0.08% 174
2024
Q3
$317K Sell
512
-5
-1% -$2.96K 0.1% 160
2024
Q2
$286K Sell
517
-34
-6% -$19.5K 0.11% 152
2024
Q1
$320K Sell
551
-7
-1% -$3.93K 0.13% 138
2023
Q4
$303K Buy
+558
New +$270K 0.14% 137

Other funds holding TMO

LongView Wealth Management's TMO Position: Q3 2026 in Review

LongView Wealth Management held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 471 shares worth $318K. The position accounts for 0.08% of the portfolio, ranked #175.

LongView Wealth Management first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $320K in Q1 2024. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • LongView Wealth Management held 471 shares of Thermo Fisher Scientific worth $318K as of Q3 2026.
  • LongView Wealth Management left its Thermo Fisher Scientific share count unchanged in Q3 2026.
  • Thermo Fisher Scientific made up 0.08% of LongView Wealth Management's portfolio in Q3 2026, its #175 holding.
  • LongView Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • LongView Wealth Management's Thermo Fisher Scientific position peaked at $320K in Q1 2024.
  • 1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on LongView Wealth Management's 13F filing for Q3 2026, filed 19 Oct 2026.